These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 31590648)

  • 21. Mortality-related factors in patients with OXA-48 carbapenemase-producing Klebsiella pneumoniae bacteremia.
    Rodríguez OL; Sousa A; Pérez-Rodríguez MT; Martínez-Lamas L; Suárez RL; Martínez CT; Pino CP; Vidal FV; Pérez-Landeiro A; Casal MC
    Medicine (Baltimore); 2021 Apr; 100(14):e24880. PubMed ID: 33832068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High mortality associated with inappropriate initial antibiotic therapy in hematological malignancies with Klebsiella pneumoniae bloodstream infections.
    Ma Z; Lai C; Zhang J; Han Y; Xin M; Wang J; Wu Z; Luo Y
    Sci Rep; 2024 Jun; 14(1):13041. PubMed ID: 38844581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbapenem-resistant hypermucoviscous
    Wang Q; Chen M; Ou Q; Zheng L; Chen X; Mao G; Fang J; Jin D; Tang X
    Front Cell Infect Microbiol; 2022; 12():1083009. PubMed ID: 36619764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Retrospective Analysis of Risk Factors and Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Bacteremia in Nontransplant Patients.
    Xiao T; Zhu Y; Zhang S; Wang Y; Shen P; Zhou Y; Yu X; Xiao Y
    J Infect Dis; 2020 Mar; 221(Suppl 2):S174-S183. PubMed ID: 32176799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization and predictors of mortality: a retrospective study.
    Jiao Y; Qin Y; Liu J; Li Q; Dong Y; Shang Y; Huang Y; Liu R
    Pathog Glob Health; 2015 Mar; 109(2):68-74. PubMed ID: 25707874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Within-host resistance evolution of a fatal ST11 hypervirulent carbapenem-resistant Klebsiella pneumoniae.
    Pu D; Zhao J; Lu B; Zhang Y; Wu Y; Li Z; Zhuo X; Cao B
    Int J Antimicrob Agents; 2023 Apr; 61(4):106747. PubMed ID: 36758779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Five-year change of prevalence and risk factors for infection and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary hospital in North China.
    Li Y; Li J; Hu T; Hu J; Song N; Zhang Y; Chen Y
    Antimicrob Resist Infect Control; 2020 Jun; 9(1):79. PubMed ID: 32487221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Colonization of Carbapenem-Resistant Klebsiella pneumoniae: Epidemiology, Resistance Mechanisms, and Risk Factors in Patients Admitted to Intensive Care Units in China.
    Qin X; Wu S; Hao M; Zhu J; Ding B; Yang Y; Xu X; Wang M; Yang F; Hu F
    J Infect Dis; 2020 Mar; 221(Suppl 2):S206-S214. PubMed ID: 32176790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization: a case-case-control study.
    Kofteridis DP; Valachis A; Dimopoulou D; Maraki S; Christidou A; Mantadakis E; Samonis G
    J Infect Chemother; 2014 May; 20(5):293-7. PubMed ID: 24703709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct prediction of carbapenem-resistant, carbapenemase-producing, and colistin-resistant Klebsiella pneumoniae isolates from routine MALDI-TOF mass spectra using machine learning and outcome evaluation.
    Yu J; Lin YT; Chen WC; Tseng KH; Lin HH; Tien N; Cho CF; Huang JY; Liang SJ; Ho LC; Hsieh YW; Hsu KC; Ho MW; Hsueh PR; Cho DY
    Int J Antimicrob Agents; 2023 Jun; 61(6):106799. PubMed ID: 37004755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of risk factors associated with healthcare-associated carbapenem-resistant Klebsiella pneumoniae infection in a large general hospital: a case-case-control study.
    Huang W; Qiao F; Deng Y; Zhu S; Li J; Zong Z; Zhang W
    Eur J Clin Microbiol Infect Dis; 2023 May; 42(5):529-541. PubMed ID: 36856898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical impact of cefepime breakpoint in patients with carbapenem-resistant Klebsiella pneumoniae bacteraemia.
    Lee NY; Lo CL; Chen PL; Syue LS; Li CW; Li MC; Ko WC
    Int J Antimicrob Agents; 2021 Feb; 57(2):106250. PubMed ID: 33264671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outbreak of carbapenem-resistant Klebsiella pneumoniae in Puerto Rico associated with a novel carbapenemase variant.
    Gregory CJ; Llata E; Stine N; Gould C; Santiago LM; Vazquez GJ; Robledo IE; Srinivasan A; Goering RV; Tomashek KM
    Infect Control Hosp Epidemiol; 2010 May; 31(5):476-84. PubMed ID: 20334553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology and outcomes of carbapenem-resistant Klebsiella pneumoniae bacteriuria in kidney transplant recipients.
    Pouch SM; Kubin CJ; Satlin MJ; Tsapepas DS; Lee JR; Dube G; Pereira MR
    Transpl Infect Dis; 2015 Dec; 17(6):800-9. PubMed ID: 26341757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-hospital Medical Costs of Infections Caused by Carbapenem-resistant Klebsiella pneumoniae.
    Huang W; Qiao F; Zhang Y; Huang J; Deng Y; Li J; Zong Z
    Clin Infect Dis; 2018 Nov; 67(suppl_2):S225-S230. PubMed ID: 30423052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Analysis of related factors of carbapenem resistant Klebsiella pneumoniae infection in patients with artificial airway].
    Bian W; Chen W; Gu X; Wang S; Liu Y; Zhao G; Qin Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Nov; 32(11):1324-1330. PubMed ID: 33463491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality.
    Rojas LJ; Salim M; Cober E; Richter SS; Perez F; Salata RA; Kalayjian RC; Watkins RR; Marshall S; Rudin SD; Domitrovic TN; Hujer AM; Hujer KM; Doi Y; Kaye KS; Evans S; Fowler VG; Bonomo RA; van Duin D;
    Clin Infect Dis; 2017 Mar; 64(6):711-718. PubMed ID: 27940944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. External validation of the INCREMENT-CPE mortality score in a carbapenem-resistant Klebsiella pneumoniae bacteraemia cohort: the prognostic significance of colistin resistance.
    Machuca I; Gutiérrez-Gutiérrez B; Rivera-Espinar F; Cano A; Gracia-Ahufinger I; Guzman-Puche J; Marfil-Pérez E; Pérez-Nadales E; Castón JJ; Bonomo RA; Carmeli Y; Paterson D; Pascual Á; Martínez-Martínez L; Rodríguez-Baño J; Torre-Cisneros J;
    Int J Antimicrob Agents; 2019 Oct; 54(4):442-448. PubMed ID: 31377343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias.
    Micozzi A; Gentile G; Minotti C; Cartoni C; Capria S; Ballarò D; Santilli S; Pacetti E; Grammatico S; Bucaneve G; Foà R
    BMC Infect Dis; 2017 Mar; 17(1):203. PubMed ID: 28283020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae.
    Xu L; Sun X; Ma X
    Ann Clin Microbiol Antimicrob; 2017 Mar; 16(1):18. PubMed ID: 28356109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.